CompletedNCT05643196
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
Device studyAges 18–50United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 50 years. Other eligibility criteria applied.
- Listed locations
- Brooklyn and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: April 6, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT05643196
- Official title
Show the full official title
A Sham-Controlled Pilot Trial of Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
Recruitment & locations
CompletedBrooklyn · New York
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 50 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
7-week Study With CT-155 in People With Schizophrenia
A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia